PROCEPT BioRobotics, Criteo, Paradox post earnings; Rackspace sued

PROCEPT BioRobotics reported second‑quarter revenue of $94.5 million, a 19 % year‑over‑year increase, but posted a loss of $0.47 earnings per share, missing analyst expectations by $0.01. The company kept its full‑year revenue guidance of $390‑$410 million and raised its operating‑expense outlook while noting slower growth in legacy AquaBeam procedures.

Criteo posted quarterly earnings of $0.80 per share, beating forecasts by $0.08, on revenue of $428.02 million, though revenue fell 11.3 % from the prior year. The firm highlighted a partnership with OpenAI and projected continued declines in enterprise client spending through 2026.

Paradox Interactive said the first half of 2026 was solid, releasing nine new pieces across seven franchises and noting strong sales for Cities: Skylines 2. The company announced a share‑buyback program following its recent listing on the Nasdaq Stockholm exchange.

Separately, Rackspace Technology faced a securities‑fraud class‑action lawsuit alleging false statements about its enterprise AI strategy and public‑cloud outlook. The complaint was filed in the Southern District of New York, with investors given until 28 September 2026 to seek lead‑plaintiff status.